Cancer

Cancer

Cancer research

Clinical Trials

Performance of clinical trials is a departmental priority. The department and affiliated programs are conducting investigational studies of treatments for genitourinary cancer and other conditions with the goal of improving diagnosis, treatment, and follow-up of urologic disease. Learn more at the Helen Diller Family Comprehensive Cancer Center.

Learn More

UCSF is internationally known for its research in prostate and other urological cancers. Our department conducts basic scientific work to analyze and categorize different types of prostate cancer and the health risks they pose. Our faculty lead large epidemiological studies on dietary and other lifestyle interventions that may help reduce the risk of the disease. UCSF Urology also heads CaPSURE™, a multicenter longitudinal study of men with prostate cancer.

In addition to our work in prostate cancer, we have important research programs in bladder, renal and other urological cancers. The department conducts clinical trials of new treatments for genitourinary cancers, coordinated through the urologic clinical and translational science program. We also maintain a urologic oncology database, which provides a valuable repository of information to guide future investigations. Many of our faculty maintain research laboratories at UCSF, where they conduct basic science investigations in their areas of expertise.

Cancer News & Highlights

  UCSF Public Affairs writer Elizabeth Fernandez reports on new research regarding prostate cancer and the benefits of substituting healthy vegetable fats – such as olive and canola oils, nuts, seeds...
As with many cancers, genetics can play a prominent role in prostate cancer. When Evan Goldberg found out he had a familial genetic mutation that raised his risk for the disease, he sought treatment...
Prostate cancer ranks as the most common internal malignancy diagnosed in men in the United States, but often does not require extensive treatment..  A study using tissue samples from men who...
Urology Department Chair Peter Carroll and prostate cancer survivor John Shoemaker are featured in UCSF Medical Center's latest multimedia advertising campaign. The video highlights our pioneering...
A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study. The test, which improves...
The University of California, San Francisco, Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S) score is a new tool updating the widely used CAPRA score with information gained from...
Urology Department Chair Peter Carroll, MD, MPH and prostate cancer survivor John Shoemaker are featured in UCSF Medical Center's latest multimedia advertising campaign. The video highlights our...